Utilization of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia
Jon D. Herrington(Scott & White Memorial Hospital), Ralph V. Boccia(Center for Cancer and Blood Disorders), Stephen L. Davidson(Auburn University at Montgomery), Larry Green(Johns Hopkins University), Robert E. Smith(United States Food and Drug Administration), Dianne Tomita
Cited by 33
Related Papers
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
|Breast Cancer Research and Treatment|2017|761
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy
|European Journal of Cancer|1993|545
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia
|New England Journal of Medicine|2010|425